Full-Time

Director – Marketing

Updated on 5/15/2024

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulation technologies for diseases

Biotechnology

Senior

Menlo Park, CA, USA

Required Skills
Marketing
Data Analysis
Requirements
  • BS/BA degree (science or business degree preferred); MBA is a plus
  • 8+ years of experience in marketing and/or relevant commercial experience in the pharmaceutical/ biotech industry, including a deep understanding of the digital space
Responsibilities
  • Develop and execute a strategic marketing plan and comprehensive marketing tactics for the ALS program
  • Build relationships and execute marketing tactics with patient advocacy groups, healthcare professionals and other key stakeholders within the ALS community
  • Develop and execute disease state education initiatives to raise awareness and build relationships with patient advocacy groups
  • Collaborate effectively with internal teams, including Regulatory, Medical Affairs and Market Access, to ensure cohesive and aligned marketing strategies
  • Develop analytics and metrics to support business objectives
  • Support national and regional congress execution, including cross-functional congress planning, booth design, and execution of commercial tactics, sponsorships, and events
  • Develop communication materials and collateral in support of business objectives and marketing tactics
  • Ensure legal/regulatory compliance and medical accuracy of all marketing materials
  • Develop the therapeutic area marketing capabilities and scalable infrastructure
  • Manage marketing budgets effectively, ensuring maximum impact and return on investment
  • Be able to support/pivot to alternative therapeutic areas as needed, demonstrating agility in responding to changing business needs

Corcept Therapeutics specializes in developing selective glucocorticoid receptor antagonists to address the adverse effects of excess cortisol in a range of diseases, with a primary emphasis on creating a new generation of compounds aimed at mitigating the effects of excess cortisol in various diseases. Their focus is on cortisol modulation technologies for endocrine, metabolic, oncologic, and psychiatric disorders, with a pipeline of over 30 ongoing studies.

Company Stage

IPO

Total Funding

$119.1M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

10%

1 year growth

19%

2 year growth

42%